Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sobrero

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Tumori|July 25, 1998
Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative GroupJ Wils, T Sahmoud, A Sobrero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 6, 2009
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008C Verslype, E Van Cutsem, M Dicato, et al.
British Journal of Cancer|October 25, 2017
Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patientsA Ruzzo, F Graziano, Fabio Galli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2008
The diagnosis and management of rectal cancer: expert discussion and recommendations derived from the 9th World Congress on Gastrointestinal Cancer, Barcelona, 2007E Van Cutsem, M Dicato, K Haustermans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2011
The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010E Van Cutsem, M Dicato, R Geva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2010
Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009E Van Cutsem, M Dicato, N Arber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 9, 2020
Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trialsT Yoshino, J M Cleary, E Van Cutsem, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2012
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision makingH J Schmoll, E Van Cutsem, A Stein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 7, 2016
ESMO consensus guidelines for the management of patients with metastatic colorectal cancerE Van Cutsem, A Cervantes, R Adam, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Tumori|July 25, 1998
Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative GroupJ Wils, T Sahmoud, A Sobrero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 6, 2009
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008C Verslype, E Van Cutsem, M Dicato, et al.
British Journal of Cancer|October 25, 2017
Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patientsA Ruzzo, F Graziano, Fabio Galli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2008
The diagnosis and management of rectal cancer: expert discussion and recommendations derived from the 9th World Congress on Gastrointestinal Cancer, Barcelona, 2007E Van Cutsem, M Dicato, K Haustermans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2011
The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010E Van Cutsem, M Dicato, R Geva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2010
Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009E Van Cutsem, M Dicato, N Arber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 9, 2020
Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trialsT Yoshino, J M Cleary, E Van Cutsem, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2012
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision makingH J Schmoll, E Van Cutsem, A Stein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 7, 2016
ESMO consensus guidelines for the management of patients with metastatic colorectal cancerE Van Cutsem, A Cervantes, R Adam, et al.
Pageof 7